FDA Approves Clesrovimab to Prevent RSV in Infants Dr. Kamal Kant Kohli20 Jun 2025 9:00 PM ISTThe FDA has approved clesrovimab, marketed as Enflonsia, for the prevention of RSV lower respiratory tract disease in neonates and infants during...
Bronchiolitis, monoclonal antibody halves hospitalizations of children younger than six months old: Study Dr. Kamal Kant Kohli19 Jun 2025 10:15 PM ISTA single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the...
Common respiratory condition nearly triples the risk of death in adults, new study finds Dr. Kamal Kant Kohli16 Jun 2025 8:15 PM ISTA major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection...
Merck RSV antibody Enflonsia gets USFDA okay for infants Ruchika Sharma10 Jun 2025 11:06 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA)...
WHO Releases First-Ever position paper on RSV Immunization for kids Dr. Kamal Kant Kohli2 Jun 2025 8:45 AM ISTThe World Health Organization (WHO) has published its first ever position paper on immunization against respiratory syncytial virus (RSV), a major...
Nirsevimab Shows Strong Real-World Protection Against Severe RSV in Infants: Lancet Dr. Kamal Kant Kohli7 May 2025 9:15 PM ISTA meta-analysis indicates that the monoclonal antibody nirsevimab offers significant real-world protection against severe respiratory syncytial virus...
Timing of RSV Immunization Matters for Infant Protection suggests study Dr. Kamal Kant Kohli5 May 2025 8:30 PM ISTThe seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring its effectiveness,...
Nirsevimab highly effective against severe RSV disease in infants: JAMA Study Jacinthlyn Sylvia18 March 2025 6:00 AM ISTA new study published in the Journal of American Medical Association showed that nirsevimab offers protection against a variety of respiratory...
Sanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab Dr. Divya Colin22 Jan 2025 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to the drug...
Merck application for RSV treatment Clesrovimab for infants accepted by USFDA Ruchika Sharma19 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted...
Medical Bulletin 13/ November/ 2024 Dr. Bhumika Maikhuri13 Nov 2024 3:00 PM ISTHere are the top medical news for the day:Can Heart Medicine Lead to Depression?All patients who have had a heart attack are typically treated using...
Researchers Highlight the Best Time for RSV Vaccine During Pregnancy Dr. Bhumika Maikhuri13 Nov 2024 8:30 AM ISTCurrent guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV)-which typically causes mild, cold-like...
